Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer
Open Access
- 3 November 2020
- Vol. 12 (11), 3238
- https://doi.org/10.3390/cancers12113238
Abstract
Inter-case variations in immune cell and fibroblast composition are associated with prognosis in solid tumors, including colon cancer. A series of experimental studies suggest immune-modulatory roles of marker-defined fibroblast populations, including FAP-positive fibroblasts. These studies imply that the fibroblast status of tumors might affect the prognostic significance of immune-related features. Analyses of a population-based colon cancer cohort demonstrated good prognosis associations of FAP intensity and CD8a density. Notably, a significant prognostic interaction was detected between these markers (p = 0.013 in nonadjusted analyses and p = 0.003 in analyses adjusted for cofounding factors) in a manner where the good prognosis association of CD8 density was restricted to the FAP intensity-high group. This prognostic interaction was also detected in an independent randomized trial-derived colon cancer cohort (p = 0.048 in nonadjusted analyses). In the CD8-high group, FAP intensity was significantly associated with a higher total tumor density of FoxP3-positive immune cells and a higher ratio of epithelial-to-stromal density of CD8a T cells. The study presents findings relevant for the ongoing efforts to improve the prognostic performance of CD8-related markers and should be followed by additional validation studies. Furthermore, findings support, in general, earlier model-derived studies implying fibroblast subsets as clinically relevant modulators of immune surveillance. Finally, the associations between FAP intensity and specific immune features suggest mechanisms of fibroblast-immune crosstalk with therapeutic potential.This publication has 45 references indexed in Scilit:
- High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosisTumor Biology, 2013
- What are regulatory T cells (Treg) regulating in cancer and why?Seminars in Cancer Biology, 2012
- Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–αScience, 2010
- High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patientsInternational Journal of Cancer, 2010
- Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent MannerCancer Cell, 2010
- Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicityProceedings of the National Academy of Sciences of the United States of America, 2009
- Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal CancerJournal of Clinical Oncology, 2009
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- ERRATUMActa Oncologica, 2006
- Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breastInternational Journal of Cancer, 2001